[go: up one dir, main page]

ZA200000167B - Sustained release tablets containing bupropion hydrochloride. - Google Patents

Sustained release tablets containing bupropion hydrochloride.

Info

Publication number
ZA200000167B
ZA200000167B ZA200000167A ZA200000167A ZA200000167B ZA 200000167 B ZA200000167 B ZA 200000167B ZA 200000167 A ZA200000167 A ZA 200000167A ZA 200000167 A ZA200000167 A ZA 200000167A ZA 200000167 B ZA200000167 B ZA 200000167B
Authority
ZA
South Africa
Prior art keywords
sustained release
tablets containing
release tablets
bupropion hydrochloride
containing bupropion
Prior art date
Application number
ZA200000167A
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Publication of ZA200000167B publication Critical patent/ZA200000167B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
ZA200000167A 1999-01-18 2000-01-17 Sustained release tablets containing bupropion hydrochloride. ZA200000167B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002259730A CA2259730A1 (en) 1999-01-18 1999-01-18 Sustained release tablets containing bupropion hydrochloride

Publications (1)

Publication Number Publication Date
ZA200000167B true ZA200000167B (en) 2000-08-07

Family

ID=4163206

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200000167A ZA200000167B (en) 1999-01-18 2000-01-17 Sustained release tablets containing bupropion hydrochloride.

Country Status (4)

Country Link
EP (1) EP1020184A1 (xx)
AU (1) AU1006600A (xx)
CA (1) CA2259730A1 (xx)
ZA (1) ZA200000167B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN192747B (xx) * 2002-04-15 2004-05-15 Ranbaxy Lab Ltd
PL196544B1 (pl) 2003-08-08 2008-01-31 Biovail Lab Int Srl Tabletka o zmodyfikowanym uwalnianiu
US7674479B2 (en) 2006-07-25 2010-03-09 Intelgenx Corp. Sustained-release bupropion and bupropion/mecamylamine tablets
US8703191B2 (en) 2006-07-25 2014-04-22 Intelgenx Corp. Controlled-release pharmaceutical tablets
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
AU8699298A (en) * 1997-08-11 1999-03-01 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention

Also Published As

Publication number Publication date
AU1006600A (en) 2000-08-10
EP1020184A1 (en) 2000-07-19
CA2259730A1 (en) 2000-07-18

Similar Documents

Publication Publication Date Title
MXPA02000725A (es) Formulacion opioide de liberacion sostenida.
ZA995445B (en) Extended release buccal tablet.
ZA200101762B (en) Immediate release tablet.
EP1247258A4 (en) SOFTWARE BASE STAMP DISTRIBUTOR
ZA200202536B (en) Pharmaceutical tramadol salts.
MXPA01010676A (es) Composicion farmaceutica de vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
MXPA03003235A (es) Formulaciones farmaceuticas de liberacion retrasada.
HUP0002469A3 (en) Solid thermoformable controlled-release pharmaceutical composition
IL146632A0 (en) Pharmaceutical tablets
MXPA02008907A (es) Capsulas.
ZA200210213B (en) Package soap bar.
ZA200203707B (en) Pharmaceutical combinations.
ZA200000857B (en) Pharmaceutical composition.
AU141186S (en) Tablet
ZA200000167B (en) Sustained release tablets containing bupropion hydrochloride.
ZA200107499B (en) Soap wrappers.
PH12001001922B1 (en) Crystalline therapeutic agent.
MXPA01012071A (es) Envase de burbujas.
GB2361643B (en) Delivery capsules
GB9929498D0 (en) Tablet package
ZA200104935B (en) Extended release buccal tablet.
ZA200005273B (en) A slow release pharmaceutical composition.
ZA99154B (en) Memorial tablets.
ZA99349B (en) A pharmaceutical formulation.
CA86061S (en) Stamp